Figure 3.
(A) Overall survival (OS) and (B) progression-free survival (PFS) rates of the patients with extensive-stage small-cell lung cancer receiving ≥4 cycles and <4 cycles of chemotherapy (ChT).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.